Get the Stockscreener App
10.25
4.76%
-0.2624
Envveno Medical Corporation stock is traded at $10.25, with a volume of 8,479.
It is down -4.76% in the last 24 hours and down -20.53% over the past month.
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
See More
Previous Close:
$10.51
Open:
$10.52
24h Volume:
8,479
Relative Volume:
0.45
Market Cap:
$6.74M
Revenue:
-
Net Income/Loss:
$-24.05M
P/E Ratio:
-4.7663
EPS:
-2.15
Net Cash Flow:
$-17.78M
1W Performance:
-14.08%
1M Performance:
-20.53%
6M Performance:
-94.23%
1Y Performance:
-91.25%
1-Day Range:
$9.98
$10.61
1-Week Range:
$9.81
$12.02
52-Week Range:
$9.81
$196.70
Envveno Medical Corporation Stock (NVNO) Company Profile
Name
Envveno Medical Corporation
Sector
Industry
Phone
949-261-2900
Address
70 DOPPLER, IRVINE
Compare NVNO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corporation
|
10.28 | 6.89M | 0 | -24.05M | -17.78M | -2.15 |
|
ABT
Abbott Laboratories
|
107.14 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.44 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
355.64 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.40 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.69 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Envveno Medical Corporation Stock (NVNO) Latest News
enVVeno Medical Announces Reverse Stock Split - ldnews.com
enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment - hattiesburgamerican.com
enVVeno Medical Executes One-for-35 Reverse Stock Split - TipRanks
EnVVeno Medical announces reverse stock split; shares down 20% - MSN
Midday Stock Roundup: loanDepot Jumps on Trump’s Proposed Mortgage Plan - Orange County Business Journal
Do Not Use - ocbj.com
enVVeno Medical Stock Set to Reverse Split on Tuesday, January 20th (NASDAQ:NVNO) - Defense World
enVVeno Medical announces 1-for-35 reverse stock split By Investing.com - Investing.com Nigeria
enVVeno Medical Approves 1-for-35 Reverse Stock Split, Reducing Shares to 655K - Intellectia AI
enVVeno Medical announces 1-for-35 reverse stock split - Investing.com
enVVeno Medical board approves 1-for-35 reverse stock split - TipRanks
What enVVeno's 1-for-35 reverse stock split means for shareholders in 2026 - Stock Titan
Midday Stock Roundup: Staar Down 4% on Board Changes - Orange County Business Journal
enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update - St. Cloud Times
enVVeno Medical presents efficacy data from SAVVE U.S. trial for VenoValve - TipRanks
Is enVVeno Medical Corporation stock ready for breakout2025 EndofYear Setup & Free Technical Confirmation Trade Alerts - ulpravda.ru
Is enVVeno Medical Corporation stock attractive for hedge fundsTrade Risk Assessment & Daily Risk Controlled Trade Plans - ulpravda.ru
Contrasting Penumbra (NYSE:PEN) & enVVeno Medical (NASDAQ:NVNO) - Defense World
Profit Review: Is enVVeno Medical Corporation (5HJ) stock worth buying before Fed action2025 Top Decliners & High Accuracy Investment Entry Signals - Улправда
Is enVVeno Medical Corporation (5HJ) stock worth buying before Fed actionWeekly Trade Recap & Accurate Entry and Exit Point Alerts - Улправда
How enVVeno Medical Corporation stock reacts to job market dataRate Hike & Precise Swing Trade Alerts - Улправда
Is enVVeno Medical Corporation stock a buy for dividend growth2025 Technical Overview & Community Verified Watchlist Alerts - Улправда
Is enVVeno Medical Corporation (5HJ) stock positioned for secular growthJuly 2025 Final Week & Short-Term Trading Opportunity Alerts - Улправда
Will enVVeno Medical Corporation stock benefit from sector rotationEntry Point & Consistent Profit Trading Strategies - Улправда
Can enVVeno Medical Corporation stock double in next 5 yearsGap Down & Daily Volume Surge Signals - Улправда
enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve - Cape Cod Times
Published on: 2026-01-08 10:56:34 - Улправда
Venous News’ top stories of 2025 - Venous News
enVVeno Medical Shares Crash After FDA Reaffirms VenoValve Rejection - MSN
NVNBW SEC FilingsEnvveno Med Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Can enVVeno Medical Corporation stock deliver sustainable ROE2025 Market Outlook & Verified High Yield Trade Plans - ulpravda.ru
Will enVVeno Medical Corporation stock pay special dividends2025 Top Decliners & Capital Efficient Trading Techniques - Улправда
How enVVeno Medical Corporation stock reacts to inflationary pressuresWeekly Risk Summary & Advanced Technical Signal Analysis - Улправда
How enVVeno Medical Corporation stock benefits from global expansion2025 Bull vs Bear & Daily Stock Momentum Reports - Улправда
Will enVVeno Medical Corporation stock sustain high P E ratios2025 Trading Volume Trends & Technical Entry and Exit Tips - Улправда
Can enVVeno Medical Corporation stock hit record highs againAnalyst Downgrade & Real-Time Market Trend Scan - Улправда
Why enVVeno Medical Corporation stock is rated strong buyJuly 2025 PostEarnings & Stepwise Trade Signal Guides - Улправда
Will enVVeno Medical Corporation stock outperform Nasdaq index2025 Trading Volume Trends & High Accuracy Investment Entry Signals - Улправда
Envveno Medical Corporation Stock (NVNO) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.07%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):